Defra is looking to reintroduce processed animal protein (PAP) into some livestock feed, which would ensure the UK is on the ...

The reintroduction of processed animal protein (PAP) into some livestock feed is on the cards, with Defra now considering ...

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Highlights: Among the broader markets, the Nifty Smallcap 100 index gained 0.12 per cent, while the Nifty Midcap 100 index ...

In this city, all roads lead to the dome. The intimidation of the U.S. Capitol itself is official dominance — no building is ...

Researchers have identified chronic wasting disease (CWD) prions in raw, cooked, and cured meat from an infected elk in Texas, confirming the presence of the infectious CWD-causing agents in muscle ...

The therapy is a critical treatment option for various life-threatening disease. Earlier, GST on gene therapy was set at 12 percent. “An New Entry 105A has been inserted in Notification No.

"Omvoh is the first biologic treatment in more than 15 years to have disclosed two-year Phase 3 efficacy data in Crohn's disease at the time of approval," the Company stated in a BSE filing. "The ...

Stock market today: BSE Sensex and Nifty50, the Indian equity benchmark indices, closed in green on Wednesday. While BSE Sensex was above 76,700, Nifty50 was over 23,200.

BSE share price: Nuvama forecasts significant growth for BSE, projecting a compound annual growth rate (CAGR) of 39.9% for revenue and 70.8% for adjusted profit after tax (APAT) from FY 2024 to 2027.

Shares of the Bombay Stock Exchange (BSE) Ltd., which have surged nearly 145% in the past year, still have room to grow, according to brokerage firm Nuvama Institutional Equities. The firm initiated ...

Shares of BSE Ltd, Asia’s oldest stock exchange, rose by 4.9% on Tuesday, reaching Rs 5,408.95 on the National Stock Exchange (NSE) after brokerage firm Jefferies upgraded its rating on the company to ...